Physician profile
Nikunjkumar Patel
NPI 1740388396
$4,719.72
in general payments reported to CMS, 2019-2025
22 companies · $1,391 in 2025
The $1,391 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $371 · 2021: $282 · 2022: $12.16 · 2023: $14.14 · 2024: $1,744 · 2025: $1,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,116 · Food and Beverage: $1,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,115.51 |
| Food and Beverage | $1,033.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,995.43 | 2024-2025 | Onyx Frontier, Micra, Symplicity G3 |
| Janssen Pharmaceuticals, INC | $221.12 | 2019-2021 | |
| Abbott Laboratories | $206.77 | 2020-2023 | Mitraclip |
| Heartflow, INC. | $173.75 | 2021 | |
| Novartis Pharmaceuticals Corporation | $160.22 | 2019-2020 | |
| Edwards Lifesciences Corporation | $131.00 | 2019 | |
| Amarin Pharma, INC. | $120.02 | 2019 | |
| Pfizer INC. | $85.31 | 2020 | |
| Inari Medical, INC. | $83.46 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $74.22 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.94 | 2019-2020 | |
| Abiomed | $64.35 | 2020-2024 | Impella |
| Amgen INC. | $61.14 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $57.20 | 2019-2020 | |
| Stryker Corporation | $49.22 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $48.21 | 2019-2020 | |
| Grifols USA, LLC | $29.09 | 2025 | Prolastin-C Liquid |
| Merit Medical Systems INC | $28.05 | 2020 | |
| Biocompatibles, INC. | $18.94 | 2019 | |
| Ascensia Diabetes Care US INC. | $18.03 | 2024 | |
| Irhythm Technologies, INC. | $12.16 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikunjkumar Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.